|
|
Previous Article | Table of Contents | Next Article 
Overexpression of mitogen-activated protein kinase (ERK1) enhances T- cell
cytokine gene expression: role of AP1, NF-AT, and NF-KB
JH Park and L Levitt
Department of Medicine, Stanford University Medical Center, CA 94305.
Transfected Jurkat cells overexpressing extracellular signal-regulated
kinase (ERK1), also referred to as mitogen-activated protein (MAP) kinase,
were selected by Western blotting assay using anti-ERK1 and
antiphosphotyrosine antibodies in combination with a functional MAP kinase
assay. We then asked whether enhanced ERK1 expression had any effect on
induction of T-cell cytokine genes. The results show that overexpression of
ERK1 enhances expression of T-cell interleukin-2 (IL- 2), IL-3, and
granulocyte-macrophage colony-stimulating factor mRNA; no change was seen
in expression of the alpha-actin gene. DNA-binding activities of the
transcription factors AP1, NF-AT, and NF-kB were specifically increased
twofold to fourfold in ERK1-overexpressing clones relative to
nontransformed or vector-transformed cells, whereas no enhancement of
CK1-CK2 protein DNA binding activity was detected after ERK1
overexpression. Additionally, increased NF-AT DNA binding activity was
associated with functional enhancement of NF-AT transactivating activity in
ERK1-overexpressing cells. These results provide direct evidence for the
role of MAP kinase in the regulation of cytokine gene expression and
indicate that such regulation is likely mediated through the enhanced DNA
binding activity of specific nuclear transcription factors.
Volume 82,
Issue 8,
pp. 2470-2477,
10/15/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Fourmentraux-Neves, A. Jalil, S. Da Rocha, C. Pichon, S. Chouaib, G. Bismuth, and A. Caignard
Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells
Blood,
September 15, 2008;
112(6):
2381 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Thusberg and M. Vihinen
The structural basis of hyper IgM deficiency - CD40L mutations
Protein Eng. Des. Sel.,
March 1, 2007;
20(3):
133 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tsukamoto, A. Irie, and Y. Nishimura
B-Raf Contributes to Sustained Extracellular Signal-regulated Kinase Activation Associated with Interleukin-2 Production Stimulated through the T Cell Receptor
J. Biol. Chem.,
November 12, 2004;
279(46):
48457 - 48465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Jenkins, D. Grail, M. Inglese, C. Quilici, S. Bozinovski, P. Wong, and M. Ernst
Imbalanced gp130-Dependent Signaling in Macrophages Alters Macrophage Colony-Stimulating Factor Responsiveness via Regulation of c-fms Expression
Mol. Cell. Biol.,
February 15, 2004;
24(4):
1453 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Morris, R. D. Lutz, H.-S. Choi, T. Kamitani, K. Chmura, and E. D. Chan
Role of the NF-{kappa}B Signaling Pathway and {kappa}B cis-Regulatory Elements on the IRF-1 and iNOS Promoter Regions in Mycobacterial Lipoarabinomannan Induction of Nitric Oxide
Infect. Immun.,
March 1, 2003;
71(3):
1442 - 1452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. San-Antonio, M. A. Iniguez, and M. Fresno
Protein Kinase Czeta Phosphorylates Nuclear Factor of Activated T Cells and Regulates Its Transactivating Activity
J. Biol. Chem.,
July 19, 2002;
277(30):
27073 - 27080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. W. Janssen-Heininger, I. Macara, and B. T. Mossman
Cooperativity between Oxidants and Tumor Necrosis Factor in the Activation of Nuclear Factor (NF)-kappa B . Requirement of Ras/Mitogen-Activated Protein Kinases in the Activation of NF-kappa B by Oxidants
Am. J. Respir. Cell Mol. Biol.,
May 1, 1999;
20(5):
942 - 952.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. NAKASHIMA, D.-H. SUN, M. C. D. TRINDADE, W. J. MALONEY, S. B. GOODMAN, D. J. SCHURMAN, and R. L. SMITH
Signaling Pathways for Tumor Necrosis Factor-{{alpha}} and Interleukin-6 Expression in Human Macrophages Exposed to Titanium-Alloy Particulate Debris in Vitro
J. Bone Joint Surg. Am.,
May 1, 1999;
81(5):
603 - 15.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Miura, J. T. Schroeder, W. C. Hubbard, and D. W. MacGlashan Jr.
Extracellular Signal-Regulated Kinases Regulate Leukotriene C4 Generation, But Not Histamine Release or IL-4 Production from Human Basophils
J. Immunol.,
April 1, 1999;
162(7):
4198 - 4206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zhang, R. A. Baumgartner, K. Yamada, and M. A. Beaven
Mitogen-activated Protein (MAP) Kinase Regulates Production of Tumor Necrosis Factor-alpha and Release of Arachidonic Acid in Mast Cells. INDICATIONS OF COMMUNICATION BETWEEN p38 AND p42 MAP KINASES
J. Biol. Chem.,
May 16, 1997;
272(20):
13397 - 13402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. McGilvray, Z. Lu, R. Bitar, A. P.B. Dackiw, C. J. Davreux, and O. D. Rotstein
VLA-4 Integrin Cross-linking on Human Monocytic THP-1 Cells Induces Tissue Factor Expression by a Mechanism Involving Mitogen-activated Protein Kinase
J. Biol. Chem.,
April 11, 1997;
272(15):
10287 - 10294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Butch and K.-L. Guan
Characterization of ERK1 Activation Site Mutants and the Effect on Recognition by MEK1 and MEK2
J. Biol. Chem.,
February 23, 1996;
271(8):
4230 - 4235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-P. Hsueh and M.-Z. Lai
c-Jun N-terminal Kinase but Not Mitogen-activated Protein Kinase Is Sensitive to cAMP Inhibition in T Lymphocytes
J. Biol. Chem.,
July 28, 1995;
270(30):
18094 - 18098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Day, Y. j. Suzuki, J. M. Lum, A. C. White, and B. L. Fanburg
Bleomycin upregulates expression of gamma -glutamylcysteine synthetase in pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol,
June 1, 2002;
282(6):
L1349 - L1357.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|